SARS-CoV-2 NP&RBD Total Antibody ELISA Kit is intended for the
determination of total antibodies (including IgA, IgM and IgG) in human serum or
plasma against SARS-CoV-2 N protein and RBD. Because of its more comprehensive
detection capabilities, the kit can be used to evaluate the immune efficacy of
not only mRNA COVID-19 vaccines, but also inactivated vaccines.
If you need kits to detect RBD antibodies alone, you can learn about SARS-CoV-2 Spike S1-RBD IgG&IgM ELISA Detection Kit (GenScript, L00845)
|Key Features||Intra-assay: One
known level of control was spiked into sample buffer as a test sample. The
sample was tested 10 times on the same plate to evaluate intra-assay precision
of the kit. Intra-assay variation of this kit is less than or equal to 10%.
Inter-assay: One known level of control was spiked into sample buffer as a test sample. The sample was tested on 3 plates which were randomly selected from 3 different lots to evaluate inter-assay precision of the kit. Inter-assay variation of this kit is less than or equal to 15%.
|Storage||The unopened kit is stable for at least 12 months from the date of manufacture if stored at 2°C to 8°C, and the opened kit is stable for up to 1 month from the date of opening at 2°C to 8°C.|
|Note||For Research Use Only. Not for Use in Diagnostic Procedures. The operator should read technical manual carefully before using this product.|
For more documents, please visit "Technical Support".